Biodegradable Stents Market Report
By Research Impact Technologies
Global Industry Analysis Market Research Report on Biodegradable Stents
– RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data.
For Discount Queries –
contactus@researchimpact.com
This study gives an insight into Global Stents and Biodegradable Stents market. Estimations and predictions for biodegradable stent market are provided from 2015-2020. Business profiles of 23 biodegradable stents companies are discussed in the report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.
Global biodegradable stents market is projected to grow at a whopping CAGR 70.10% during the analysis period 2015-2020. Europe, following North America, is projected as the second largest market for Biodegradable Stents. Bioresorbable polymeric stents have become popular alternative for metallic stents as these can remain in situ for a predetermined period of time, these keep the wall of the blood vessel intact and ultimately disintegrates to non-toxic substances. A major part of the problems related to the metal stents are solved with this stent. There is evidence to support the fact that the use of bioresorbable coronary stent reduces the necessity for a substitute part after half a year. The use of bioresorbable stents is advocated in such cases where removal surgery is difficult. For e.g. in case of treatment of tracheomalacia in newborns and infants. The bioresorbable stents can help to release drugs and proteins into the blood through an intermediary wall. The biodegradable metal of magnesium alloy which was hitherto used as an orthopedic implant is now gaining popularity as a cardiovascular implant. Of these, WE43 and AE21 are a few that have gained importance as stent material.
This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
Synopsis of the report summarizes the global stent market, by Type (Drug Eluting Stents & Bare Metal) and by Application (Coronary Arterial Stents, Peripheral Arterial Stents and Other). List of major global companies is also provided.
Market Dynamics chapter provides information on global markets for both Stents and Biodegradable Stents. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific and Rest of World. The chapter provides market values (2005 - 2015) in US$ for each geographic region. The section includes key market trends and an industry outlook.
This chapter includes brief business profiles of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc.
This chapter gives an insight into various Stenting Technologies including definitions, segmentation and applications. Biodegradable stents under development and their respective methods, compositons, and importance/applications are also discussed. Various research activities in the field of Biodegradable Stents finds a mention in this chapter.
This chapter provides a global region-wise list of 20 plus companies engaged in the development of Biodegradable Stents.
This chapter provides a compilation of worldwide patents related to Biodegradable Stents.
480 Biomedical (USA)
Abbott Vascular (USA)
American Medical Systems, Inc. (USA)
Arterial Remodeling Technologies (ART) (France)
Arterius Ltd. (UK)
Biotronik SE & Co. KG (Germany)
Boston Scientific Corporation (USA)
Bristol-Myers Squibb Company (USA)
Cedars-Sinai Medical Center (USA)
Cordis Corporation (USA)
Duke University (USA)
Elixir Medical Corporation (USA)
ELLA-CS, s.r.o. (Czech Republic)
Ethicon, Inc. (USA)
Eurocor GmbH (Germany)
JMS Co., Ltd. (Japan)
Kyoto Medical Planning Co., Ltd. (Japan)
Medicines Co. (The) (USA)
Medtronic, Inc. (USA)
Poly-Med, Inc. (USA)
Reva Medical Inc. (USA)
Tepha, Inc. (USA)
Xenogenics Corporation (USA)
1. SCOPE AND METHODOLOGY
1.1 Scope of the Study
1.2 Research Methodology
1.3 Units and Currency
2. REPORT SYNOPSIS
2.1 Introduction
Types of Stents
Bare-Metal Stents
Drug Eluting Stents (DES)
Everolimus
Sirolimus
Biolimus A9
Pimecrolimus
Biodegradable Stents
Raw Materials
Polymeric Stents
Degradation of Biodegradable Polymers
Processing of Biodegradable Polymers
Role of Biodegradable Polymers
In Tissue Engineering
In Controlling Drug Delivery
Application
Polymer based Stents
Igaki-Tamai Stent
ReZolve Stent
Metal Stents
Bioabsorbable Metal based Stents
Magnesium Stents
Applications of Biodegradable Stents
2.2 Segmentation
Exhibit 1. Segmentation of Biodegradable Stents Market by Application Area (2015 - 2020)
2.3 Stents - Global Market Analysis
Exhibit 2. Stents - Global Value Market Historic, Current, and Forecast (2005 -2020) in US$ Billion
2.4 Biodegradable Stents - Global Market Analysis
Exhibit 3. Biodegradable Stents - Global Value Market Current and Forecast (2015 -2022) in US$ Million
Exhibit 4. List of Global Major Companies in Biodegradable Stents Market
3. MARKET DYNAMICS
3.1 Global Biodegradable Stents Market
Exhibit 5. Biodegradable Stents Global Value Market Current and Forecast (2015 -2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 6. Biodegradable Stents Global Value Market Shares (2015 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
Exhibit 7. Biodegradable Stents Global Value Market Current and Forecast (2015 -2022) by Application Area for Coronary Arterial Disease, Peripheral Arterial Disease and Other in US$ Million
Exhibit 8. Biodegradable Stents Global Value Market Shares (2015 & 2022) by Application Area for Coronary Arterial Disease, Peripheral Arterial Disease and Other
3.2 Biodegradable Stents Market Outlook
4. COMPETITOR DYNAMICS
4.1 Biodegradable Stents - Major Company Profiles
480 Biomedical (USA)
Abbott Vascular (USA)
American Medical Systems, Inc. (USA)
Arterial Remodeling Technologies (ART) (France)
Arterius Ltd. (UK)
Biotronik SE & Co. KG (Germany)
Boston Scientific Corporation (USA)
Bristol-Myers Squibb Company (USA)
Cedars-Sinai Medical Center (USA)
Cordis Corporation (USA)
Duke University (USA)
Elixir Medical Corporation (USA)
ELLA-CS, s.r.o. (Czech Republic)
Ethicon, Inc. (USA)
Eurocor GmbH (Germany)
JMS Co., Ltd. (Japan)
Kyoto Medical Planning Co., Ltd. (Japan)
Medicines Co. (The) (USA)
Medtronic, Inc. (USA)
Poly-Med, Inc. (USA)
Reva Medical Inc. (USA)
Tepha, Inc. (USA)
Xenogenics Corporation (USA)
4.2 Major Activities/Product Launches
First implantation of Elixir Medicals DESolve Novolimus Eluting Coronary Scaffold System in Europe
BIOTRONIK Reports Use of FirstinHuman Use of Bioabsorbable Magnesium DREAMS Scaffold
Elixir Reports Outstanding 1-year Results for Safety and Efficacy for 100% Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
Elixir's DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System Certified by CE
Asian Heart Institute Conducts Angioplasty with New Generation Biodegradable Stent
Elixir Medical Finalizes the Enrollment for the DESolve Nx Pivotal Trial Carried Out for Fully Bioresorbable Coronary Scaffold System
REVA Medical Presents the First Follow-Up Imaging Assessment of the ReZolve Scaffold
Arterial Remodeling Technologies (ART) Announces First Human Use of Its Bioresorbable Stent
Biotronik Announces Positive Results from BIOSOLVE-I trial
American Heart Association Reports Igaki Tamai Biodegradable Stent Safe for Long-Term Treatment of Coronary Artery Disease
Reva Medicals ReZolve Stent Bring a New Revolution to Cardiology: Claims to Stop Heart Attacks before they Occur with Resorbable Stents
S3V Vascular Technologies Introduces first Bioabsorbable Endovascular Drug Coated Stent "3V-Avatar"in India
Abbott Initiates Clinical Trial to Evaluate and compare Absorb Bioresorbable Vascular Scaffold and Metallic Drug Eluting Stent
Abbott Begins Clinical Trials for ABSORB BTK, to treat Below-the-Knee Limb Ischemia
UK Medical Launches the First Ever Biodegradable Esophageal Stent
Abbott Announces the Success of International Clinical Trial of 'ABSORB', a Bioresorbable Vascular Scaffold in Japan.
Arterius Ltd. Signs a New Research Collaboration
Abbott Announces the Success of Second Trial of 'ABSORB', a Bioresorbable Vascular Scaffold
Abbott Announces the CE Marking on ABSORB in Europe, World's First Drug Eluting Bioresorbable Vascular Scaffold
Biodegradable Stent Implanted in India
Xenogenics Completes the Acquisition of the Assets of Ideal BioStent
Biodegradable Heart Stent Study Findings
ART Raises US$ 8.5M for Biodegradable Stents
IGAKI-TAMAIs Bioabsorbable Stent Gains CE Mark Status for Peripheral Artery
Abbott Develops Effective Bioabsorbable Stent
5. PRODUCT TECHNOLOGY/RESEARCH
5.1 Introduction
Exhibit 9. Comparative Features - Bare Metal Stent, Drug Eluting Stent and Biodegradable Stent
Design and Composition
Raw Materials for Biodegradable Stents Synthesis
Biopolymers Used in Stents
Controlling properties
Mechanical performance
The chemistry of polymers
The selection of the materials
The steps in the processing
The degradations aspects
Exhibit 10. Characteristics of Widely Used Biodegradable polymers
Poly Lactic Acid
SR-PLA- Biodegradable Stents
Poly-Caprolactone
Polyglycolide
Biodegradable Metallic Stents
Iron-based Biodegradable Stents
Magnesium-based Biodegradable Stents
Fabrication of Biodegradable Stents
Exhibit 11. Biodegradable Stents By Degradation Time and Biodegradable Material Used
Powder Metallurgy
Electroforming
Passivation Methods
Oxide Films
Electropolishing
Coatings
Nitinol & its Biocompatibility
Effect of Surface Passivation on Biocompatibility
Welding
Time Factor
Mechanical Property of Biodegradable Stents
Polymer Mechanical Property
Polymer Degradation
Comparison of Biodegradable Stents with Other Stents
Cost
Significance of Clinical Trials
Drug for Biodegradable Stents
Heparin
Sirolimus
Paclitaxel
Limitations
Advantages
Applications
Cardiovascular Disease
Ischemic Heart Disease
Congenital Heart Disease
Early Attempts to Treat CHD
5.2 Biodegradable Stents - Research Briefs
Biodegradable Magnesium Alloy for Medical Devices
A 59 year Old Implanted with Biodegradable Stent
Characteristics and Cyto-Compatibility of Biodegradable Polymer Film on Magnesium by Spin Coating
A Novel Radioplaque Biodegradable Stent for Pancreatobiliary Applications
Biodegradable Stent Found to be Safe for Long-term Therapy of Coronary Artery Disease
Biodegradable Stent proven to be Safe for Long-Term Treatment of Coronary Artery Disease
Biodegradable Stent and Hyper Granulation Causing Re-Stenosis Risk
Biodegradable Bifurcation Stents
Rabbit Airway Model Using New Biodegradable Polydioxanone Stents
Magnesium based bioabsorbable stents Inhibits Smooth Muscle Proliferation and Stimulates Endothelial Cells In Vitro
Biodegradable Stent for the Treatment of Benign Colorectal Anastomotic Stricture
In Vivo Study of Biodegradable Biliary Duct Stent
A New Potential Composite of MAO/PLLA using Modified Magnesium Alloy WE42 Developed
Use of Corrosion Model for Bioabsorbable Metallic Stents
New, Biodegradable Heart Stent Prove Safe in Trials
Clinical Follow-up Results of Biodegradable Stents (EXCEL) and Durable Polymer Stent (CYPHER) in Treating Coronary Artery Disease
Biodegradable Stents for Bronchial Stenosis Treatment
In Vivo Study of Biodegradable Poly (Trimethylene Carbonate-co-D, L-Lactide) Stent
Bio-Absorbable Stent for Treating CAD
Modeling of Deformation-Accelerated Breakdown of Polylactic Acid Biodegradable Stents
Biodegradable Stents for the First Time in India
The BEST (Biodegradable Esophageal Stent) study
Biodegradable Cardiovascular Stent Material Developed Using Electroformed Iron
Polydioxanone Biodegradable Stents for the Management of Benign Intrahepatic Bile Duct Strictures
Tomography Study of a Biodegradable Stents compared to Durable Polymer-Coated Limus Eluting Stent
Coating Bio-Absorption and Chronic Bare Metal Scaffolding versus Fully Bio-Absorbable Stent
Researcher Develops Biodegradable Stent for Hearts Patients
Biodegradable Stent and Severe Epithelial Hyperplasia Complication
A Potential, Non-Randomized Multicenter Clinical Trial of Absorbable Magnesium Stents for Coronary Implants
Biodegradable Heart Stents
Absorbable Metal Stents
Drug-Eluting and Absorbable Stents Push Interventional Frontiers Separate Study Fine-Tunes Timing of Anti-Clotting Drugs
First Successful Implantation of a Biodegradable Metal Stent into the Left Pulmonary Artery of a Preterm Baby
Implantation of the First Absorbable Metal Stents (AMS) in Humans
Assessment of a Dissolvable Urethral Drainage Stent in a Swine Model
Biodegradable Stents A Disappearing Act
Biodegradable Polyglycolic Acid Spiral Stent and Endoscopic Urethroplasty
6. CORPORATE DIRECTORY
7. PATENTS
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Analytics and data presented in each report pertain to several parameters such as –
This study gives an insight into Global Stents and Biodegradable Stents market. The Bio degradable market research report also provides an overview of the Worldwide Bare Metal Stents and Drug Eluting Stents market size. Market analytics for Biodegradable Stents by Application and by Biodegradable Material is provided in this niche report. The market is divided by Application into Coronary Arterial Stents, Peripheral Arterial Stents and Other; and by Biodegradable Material into Polymer and Metal. Global stents market is analyzed from 2005 -2020, while estimations and predictions for biodegradable stents market are provided from 2015-2020. Key market dynamics are provided for North America, Europe, Asia-Pacific, and Rest of World (RoW).
